Enhanced antitumor effect of EGF R-targeted p21WAF-1 and GM-CSF gene transfer in the established murine hepatoma by peritumoral injection

Cancer Gene Therapy

Volumn 9, Issue 1, 2002, Pages 100-108

  Liu, Xiang ^a   Tian, Peikun ^a   Yu, Yizhi ^b   Yao, Ming ^a   Cao, Xuetao ^b   Gu, Jianren ^a  

^a SHANGHAI CANCER INSTITUTE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Gene therapy; GM CSF; Hepatoma; Nonviral vector; p21WAF 1

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; CYTOKINE; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; OLIGOPEPTIDE; PROTEIN GE7; PROTEIN P21; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CONTROLLED STUDY; DRUG POTENCY; FEMALE; GENE DELIVERY SYSTEM; GENE THERAPY; GENE TRANSFER; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; TREATMENT OUTCOME;

ANIMALS; BETA-GALACTOSIDASE; CARCINOMA, HEPATOCELLULAR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; GENE THERAPY; GENES, ERBB-1; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOENZYME TECHNIQUES; INJECTIONS, INTRALESIONAL; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C57BL; PLASMIDS; SURVIVAL RATE; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA; MURINAE;

EID: 85047699262     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700400     Document Type: Article

References (42)

1. Epidermal growth factor mediated DNA delivery into lung cancer cells via the epidermal growth factor receptor
2. HER2-targeted gene transfer
3. Gene delivery by an epidermal growth factor/DNA polyplex to small cell lung cancer cell lines expressing low levels of epidermal growth factor receptor
4. Cationic liposome-mediated gene delivery to the liver and to hepatocellular carcinomas in mice
5. A novel receptor-targeted gene delivery system for cancer gene therapy
6. A novel gene delivery system targeting cells expressing VEGF receptors
7. Epidermal growth factor receptor in human hepatocellular carcinoma
8. Combined chemokine and cytokine gene transfer enhances antitumor immunity
9. p53 tumor suppressor gene therapy for cancer
10. Adenovirus-mediated lymphotactin gene transfer improves therapeutic efficacy of cytosine deaminase suicide gene therapy in established murine colon carcinoma
11. Pronounced antitumor effects and tumor radio sensitization of double suicide gene therapy
12. Enhanced adjuvant effect of granulocyte-macrophage colony- stimulating factor plus interleukin-12 compared with either alone in vaccine-induced tumor immunity
13. Adenovirally transferred p16INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death
14. Combination therapy with interleukin-2 and wild-type p53 expressed by adenoviral vectors potentiates tumor regression in a murine model of breast cancer
15. Enhanced antitumoral effect of adenovirus-mediated cytosine deaminase gene therapy by induction of antigen-presenting cells through stem cell factor/granulocyte-macrophage colony-stimulating factor gene transfer
16. Wild-type p53 can induce p21 and apoptosis in neuroblastoma cells but the DNA damage-induced GI checkpoint function is attenuated
17. Inhibition of tumor cell growth by p21WAF1 adenoviral gene transfer in lung cancer
18. Expression of cyclindependent kinase inhibitor genes induces apoptosis in human hepatoma cell line
19. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity
20. Local and systemic effects after adenoviral transfer of the murine granulocyte-macrophage colony- stimulating factor gene into mice
21. Adenovirus-mediated GM-CSF gene and cytosine deaminase gene transfer followed by 5-fluorocytosine administration elicit more potent antitumor response in tumor-bearing mice
22. Therapy of established tomour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells
23. Intratumoral injection of GM-CSF gene encoded recombinant vaccinia virus elicits potent antitumor response in a mixture melanoma model
24. Membrane fusion induced by mutual interaction of the two charge-reversed amphiphilic peptides at neutral pH
25. Immunohistochemical analysis of human CD5 positive B cells: Mantle cells and mantle cell lymphoma are not equivalent in terms of CD5 expression
26. "Western blotting": Electrophoretic transfer of proteins from sodium dodecyl sulfate - Polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A
27. Locally advanced, unresectable non-small cell lung cancer: New treatment strategies
28. Liver-directed gene therapy: Promises, problems and prospects at the turn of the century
29. The clinical value of p21WAF1/CIP1 expression in superficial bladder cancer
30. Transforming growth factor-beta-mediated p15(INK4B) induction and growth inhibition in astrocytes is SMAD3-dependent and a pathway prominently altered in human glioma cell lines
31. P161NK4a expression adenovirus vector to suppress pancreas cancer cell proliferation
32. Uses of granulocyte-macrophage colony-stimulating factor in vaccine development
33. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age
34. Cell-cycle arrest versus cell death in cancer therapy
35. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
36. p53-dependent apoptosis suppresses tumor growth and progression in vivo
37. Apoptosis in cancer therapy: Crossing the threshold
38. Preclinical development of human granulocyte-macrophage colony-stimulating factor-transfected melanoma cell vaccine using established canine cell lines and normal dogs
39. Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand
40. Immunogenetic therapy of human melanoma utilizing autologous tumor cells transduced to secrete granulocyte-macrophage colony-stimulating factor
41. Presentation of MUCI tumor antigen by class I MHC and CTL function correlate with the glycossylation state of the protein taken Up by dendritic cells
42. Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway